US Patent Issued to THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, VANQUISH ONCOLOGY, The Johns Hopkins University on Oct. 7 for "Procaspase combination therapy for glioblastoma" (Illinois, Washington, Colorado, California, Maryland Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,885, issued on Oct. 7, was assigned to THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (Urbana, Ill.), VANQUISH ONCOLOGY INC. (Champaign, Ill.) and The Johns Hopkins University (Baltimore).

"Procaspase combination therapy for glioblastoma" was invented by Paul J. Hergenrother (Champaign, Ill.), Rachel C Botham (Champaign, Ill.), Timothy M. Fan (Mahomet, Ill.), Mark J. Gilbert (Seattle), Michael K. Handley (Windsor, Colo.), Avadhut Joshi (Towson, Md.), Gregory J. Riggins (White Hall, Md.) and Theodore M. Tarasow (San Ramon, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods for the induction of cell death, for example, ...